Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Drug Deliv. 2014 Jun 5;23(3):968–980. doi: 10.3109/10717544.2014.923068

Figure 5.

Figure 5

Physical stability of DTX containing non-targeted and folate targeted NE formulations upon 90% dilution in dog plasma, parenteral infusion fluids (5% dextrose and 0.9% sodium chloride) and phosphate buffered saline. The data are shown as mean ±SD (n=3).